Waters launches BD FACSDiscover A7 Cell Analyzer globally
The new spectral flow cytometer enables 50+ parameter experiments with industry-leading standardization to accelerate cancer research.
See the latest news and media coverage for Waters. We track all announcements, press releases, and industry mentions in real time, all in one place.
Analytical laboratory instruments, consumables, software, and services
waters.comLast updated
In short: Waters exceeded Q2 2026 financial expectations, raised its growth outlook, and launched high-sensitivity mass spectrometry platforms.
The new spectral flow cytometer enables 50+ parameter experiments with industry-leading standardization to accelerate cancer research.
The ELIT-based platform measures individual ions, distinguishes empty and full AAV capsids, and analyzes virus-like particles up to 350 MDa.
Total revenue reached $1.645 billion, exceeding guidance, while adjusted EPS was $3.05, and the company raised full-year guidance.
Xevo TQ Absolute XR IVD Mass Spectrometer offers 5x greater sensitivity and enhanced robustness for clinical applications.
Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences...
In addition to the share price ... mid cap or smaller large cap companies in the analytical instruments and life sciences tools sector. For investors...
Q2 2026 earnings call highlights: raised 2026 guidance, 7-9% organic growth, cost savings, FX/China risks and EPS outlook—read now.
Scientific instruments company Waters Corporation (NYSE:WAT) announced better-than-expected revenue in Q2 CY2026, with sales up 113% year on year to $1.65 billion. The company expects...
Track Waters and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Waters and other trending companies.